
Last update at 2026-06-18T13:30:00Z
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
| Breakdown | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
| Income before tax | 65499.00M | 76032.00M | 54967.00M | 46283.00M | 33040.00M |
| Minority interest | -996.00000M | -710.00000M | -958.00000M | -799.00000M | 7148.00M |
| Net income | 49480.00M | 55834.00M | 40682.00M | 31254.00M | 19713.00M |
| Selling general administrative | 56502.00M | 54762.00M | - | - | - |
| Selling and marketing expenses | 22394.00M | 19839.00M | - | - | - |
| Gross profit | 164746.00M | 159280.00M | 145812.00M | 138608.00M | 111432.00M |
| Reconciled depreciation | 41373.00M | 33703.00M | 31575.00M | 28195.00M | 27404.00M |
| Ebit | 67480.00M | 77698.00M | 53467.00M | 58653.00M | 35878.00M |
| Ebitda | 108853.00M | 111401.00M | 85042.00M | 86848.00M | 63282.00M |
| Depreciation and amortization | 41373.00M | 33703.00M | 31575.00M | 28195.00M | 27404.00M |
| Non operating income net other | - | - | - | - | - |
| Operating income | 61011.00M | 62393.00M | 47508.00M | 50697.00M | 31723.00M |
| Other operating expenses | 525520.00M | 495663.00M | 490517.00M | 417239.00M | 361844.00M |
| Interest expense | 1981.00M | 1666.00M | 1432.00M | 1361.00M | 1195.00M |
| Tax provision | 15022.00M | 19487.00M | 13326.00M | 14229.00M | 10605.00M |
| Interest income | 1205.00M | 1565.00M | 697.00M | 236.00M | 225.00M |
| Net interest income | -778.00000M | -103.00000M | -736.00000M | -1125.00000M | -1427.00000M |
| Extraordinary items | - | - | - | - | - |
| Non recurring | - | - | - | - | - |
| Other items | - | - | - | - | - |
| Income tax expense | 15022.00M | 19487.00M | 13326.00M | 14229.00M | 10605.00M |
| Total revenue | 586531.00M | 558056.00M | 538026.00M | 467937.00M | 393568.00M |
| Total operating expenses | 103735.00M | 96887.00M | 98303.00M | 87910.00M | 79708.00M |
| Cost of revenue | 421785.00M | 398776.00M | 392214.00M | 329329.00M | 282136.00M |
| Total other income expense net | 4488.00M | 13639.00M | 7459.00M | -4414.00000M | 1317.00M |
| Discontinued operations | - | - | - | - | - |
| Net income from continuing ops | 50477.00M | 56545.00M | 41641.00M | 32054.00M | 22435.00M |
| Net income applicable to common shares | - | - | - | 31254.00M | 19713.00M |
| Preferred stock and other adjustments | - | - | - | - | - |
| Breakdown | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
| Total assets | 813831.00M | 839169.00M | 765606.00M | 698836.00M | 640385.00M |
| Intangible assets | 10575.00M | 10688.00M | 10853.00M | 9703.00M | 8197.00M |
| Earning assets | - | - | - | - | - |
| Other current assets | 38671.00M | 39428.00M | 34084.00M | 25156.00M | 19170.00M |
| Total liab | 438796.00M | 464311.00M | 455173.00M | 419294.00M | 395385.00M |
| Total stockholder equity | 359983.00M | 358894.00M | 295208.00M | 272016.00M | 237852.00M |
| Deferred long term liab | - | - | - | - | - |
| Other current liab | 64943.00M | 55193.00M | 55680.00M | 47537.00M | 51120.00M |
| Common stock | 36275.00M | 36275.00M | 36275.00M | 36275.00M | 36275.00M |
| Capital stock | 36275.00M | 36275.00M | 36275.00M | 36275.00M | 36275.00M |
| Retained earnings | 253721.00M | 233115.00M | 204529.00M | 174500.00M | 152816.00M |
| Other liab | - | - | - | 29367.00M | 27248.00M |
| Good will | 66.00M | 85.00M | 338.00M | 363.00M | 2410.00M |
| Other assets | 2.00M | 3.00M | 4.00M | 2.00M | 2.00M |
| Cash | 65142.00M | 73183.00M | 93840.00M | 88130.00M | 90827.00M |
| Cash and equivalents | - | - | - | - | - |
| Total current liabilities | 210353.00M | 208804.00M | 220856.00M | 153898.00M | 112566.00M |
| Current deferred revenue | - | 6378.00M | 8908.00M | 5737.00M | 7434.00M |
| Net debt | 215777.00M | 226607.00M | 223992.00M | 192372.00M | 176771.00M |
| Short term debt | 72898.00M | 85049.00M | 109009.00M | 44473.00M | 12027.00M |
| Short long term debt | 72898.00M | 85049.00M | 109009.00M | 44473.00M | 12027.00M |
| Short long term debt total | 280919.00M | 299790.00M | 317832.00M | 280502.00M | 267598.00M |
| Other stockholder equity | 69987.00M | -15895.00000M | 54404.00M | 61241.00M | 48761.00M |
| Property plant equipment | - | - | - | 229843.00M | 219720.00M |
| Total current assets | 395626.00M | 409481.00M | 406627.00M | 360247.00M | 312524.00M |
| Long term investments | - | - | - | - | - |
| Net tangible assets | - | - | - | 261950.00M | 227245.00M |
| Short term investments | - | -27547.00000M | - | 2398.00M | 709.00M |
| Net receivables | 113934.00M | 114360.00M | 101534.00M | 102561.00M | 93159.00M |
| Long term debt | 208021.00M | 214741.00M | 208823.00M | 236029.00M | 255571.00M |
| Inventory | 177879.00M | 182510.00M | 177169.00M | 142002.00M | 108659.00M |
| Accounts payable | 61239.00M | 62184.00M | 56167.00M | 61888.00M | 49419.00M |
| Total permanent equity | - | - | - | - | - |
| Noncontrolling interest in consolidated entity | - | - | - | - | - |
| Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
| Accumulated other comprehensive income | - | 105399.00M | - | - | - |
| Additional paid in capital | - | - | - | - | - |
| Common stock total equity | - | - | - | - | - |
| Preferred stock total equity | - | - | - | - | - |
| Retained earnings total equity | - | - | - | - | - |
| Treasury stock | - | - | - | - | - |
| Accumulated amortization | - | - | - | - | - |
| Non currrent assets other | 28406.00M | 2393.00M | 89229.00M | 25356.00M | 21367.00M |
| Deferred long term asset charges | - | - | - | - | - |
| Non current assets total | 418203.00M | 429685.00M | 358975.00M | 338587.00M | 327859.00M |
| Capital lease obligations | - | - | - | - | - |
| Long term debt total | - | - | - | - | - |
| Breakdown | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
| Investments | -47869.00000M | -55374.00000M | -44093.00000M | 2589.00M | 4133.00M |
| Change to liabilities | - | - | - | 7924.00M | 2183.00M |
| Total cashflows from investing activities | -47869.00000M | -55374.00000M | - | -46528.00000M | -34220.00000M |
| Net borrowings | -16446.00000M | -22055.00000M | - | 11363.00M | 176997.00M |
| Total cash from financing activities | -48855.00000M | -52373.00000M | 19956.00M | -5452.00000M | -17050.00000M |
| Change to operating activities | - | - | - | -8928.00000M | 384.00M |
| Net income | 65499.00M | 55834.00M | 54967.00M | 46283.00M | 33040.00M |
| Change in cash | -3641.00000M | -25085.00000M | 5507.00M | -2761.00000M | 10073.00M |
| Begin period cash flow | 68408.00M | 93493.00M | 87986.00M | 90747.00M | 80674.00M |
| End period cash flow | 64767.00M | 68408.00M | 93493.00M | 87986.00M | 90747.00M |
| Total cash from operating activities | 93406.00M | 76729.00M | 26847.00M | 42993.00M | 57869.00M |
| Issuance of capital stock | - | 0.00000M | 0.00000M | - | - |
| Depreciation | 41373.00M | 33703.00M | 31575.00M | 28195.00M | 27404.00M |
| Other cashflows from investing activities | 706.00M | -8524.00000M | - | -1877.00000M | -2429.00000M |
| Dividends paid | 15170.00M | 12859.00M | 10651.00M | 9645.00M | 10415.00M |
| Change to inventory | 2812.00M | 1420.00M | -31875.00000M | -27480.00000M | 11091.00M |
| Change to account receivables | -250.00000M | -6177.00000M | - | -3429.00000M | -10846.00000M |
| Sale purchase of stock | -15000.00000M | -15000.00000M | -10000.00000M | -4983.00000M | -8286.00000M |
| Other cashflows from financing activities | -2239.00000M | -2459.00000M | 63717.00M | 14213.00M | 12135.00M |
| Change to netincome | - | - | - | 428.00M | -5387.00000M |
| Capital expenditures | 72342.00M | 69208.00M | 51923.00M | 47471.00M | 36789.00M |
| Change receivables | - | - | - | - | - |
| Cash flows other operating | - | - | - | - | - |
| Exchange rate changes | - | - | - | - | - |
| Cash and cash equivalents changes | - | - | - | - | - |
| Change in working capital | 5654.00M | -9744.00000M | -36094.00000M | -23041.00000M | 351.00M |
| Stock based compensation | - | - | - | - | - |
| Other non cash items | -19120.00000M | -3064.00000M | -23601.00000M | -8444.00000M | -2926.00000M |
| Free cash flow | 21064.00M | 7521.00M | -25076.00000M | -4478.00000M | 21080.00M |
Sector: Basic Materials Industry: Specialty Chemicals
| Company | Change (USD) | Price (USD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| DACHF Daicel Corporation |
- -% | 8.00 | 12.43 | - | 0.0047 | 0.85 | 0.98 | 5.92 |
| LIN Linde plc Ordinary Shares |
4.56 0.89% | 516.71 | 33.77 | 28.90 | 6.56 | 5.42 | 7.03 | 18.92 |
| AIQUY Air Liquide SA ADR |
-0.61 1.59% | 37.81 | 30.69 | 24.81 | 4.70 | 4.10 | 4.36 | 15.61 |
| AIQUF L'Air Liquide S.A |
0.0013 0.0007% | 190.41 | 30.66 | 24.51 | 4.69 | 4.05 | 4.36 | 15.61 |
| SHW Sherwin-Williams Co |
-3.89 1.21% | 316.90 | 33.33 | 27.40 | 3.38 | 20.60 | 3.88 | 21.36 |
Daicel Corporation engages in the materials, medical/healthcare, smart, safety, and engineering plastics businesses in Japan and internationally. The company offers medical/healthcare products, including BELLOCEA S7, a spherical cellulose acetate particle; FLAVOCELL S-Equol; Urolithin A; polyglycerols; konjac ceramide; excipients for foods; chiral columns and reagents; and Actranza lab, as well as separation and analytical services. It also provides performance films, solvents for electronic materials, cycloaliphatic epoxies, polymers for photoresists, optical lenses, and caprolactone derivatives; functional films and materials used in smartphones, PCs, TVs, and in-vehicle displays, polymers and solvents; and lenses used in VR, smartphones and various sensors. In addition, the company offers airbags inflators, pyro-fuses, and gas generators for seat belt pretensioners; acetic acid, acetic acid derivatives, acetate tow, ketene / diketene derivatives, cellulose acetate for LCD optical films, amines, and 1,3-butylene glycol; and reverse osmosis membrane and ultrafiltration membrane products, as well as water treatment systems. Further, it provides Engineering plastics comprising polyacetal, polybutylene terephthalate, polyphenylene sulfide, liquid crystal polymer, and cyclic olefin copolymer; AS resin, acetate plastics, water-soluble polymers, and barrier films for packaging; ABS resins, various polymer alloys, plastic compounds; Polyamide-12 and PEEK resin; and various molded containers. The company's products are used in transportation, electronics, medical care, personal care, everyday life, and environment and energy applications. The company was formerly known as Daicel Chemical Industries, Ltd. and changed its name to Daicel Corporation in October 2011. Daicel Corporation was incorporated in 1919 and is headquartered in Osaka, Japan.
Grand Front Osaka Tower-B, Osaka, Japan, 530-0011
| Name | Title | Year Born |
|---|---|---|
| Mr. Yoshimi Ogawa | Pres, CEO & Director | NA |
| Naohide Hakushi | Managing Exec. Officer, GM of Himeji Production Sector & Aboshi Plant | NA |
| Hidekage Kojima | Sr. Managing Exec. Officer | NA |
| Mr. Dieter Heckmann | Managing Exec. Officer | NA |
| Mr. Yasuhiro Sakaki | Sr. Managing Exec. Officer, Head of Strategic Planning & Director | NA |
| Mr. Kotaro Sugimoto | Sr. Managing Exec. Officer, Head of Corp. Support Headquarters & Director | NA |
| Takashi Ueno | Managing Exec. Officer, Head of Production Management Headquarters & GM of Ohtake Plant | NA |
| Mr. Akihisa Takabe | Managing Exec. Officer, Head of Innovation & Bus. Devel. Headquarters and Director | NA |
| Naotaka Kawaguchi | Managing Exec. Officer | NA |
| Ikuo Takahashi | Exec. officer, GM of Innovation Park & Head of Corp. Reserch Center | NA |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.